[1]
“Seroprevalence of Hepatitis C Virus among Risk Groups in MosulCity”, Tikrit J. Pharm. Sci., vol. 3, no. 2, pp. 138–141, Apr. 2023, doi: 10.25130/tjphs.2007.2.8.138.141.